Consensus definition of rapidly progressive interstitial lung disease: a critical unmet need to be led by pneumologists

<title>Extract</title> The recent European Respiratory Society (ERS)/European Alliance of Associations for Rheumatology (EULAR) clinical practice guidelines for connective tissue disease-associated interstitial lung disease (CTD-ILD) represent a commendable collaborative effort and an important step toward harmonising clinical practice and improving outcomes for patients with these complex disorders [1, 2]. We commend the authors for addressing key aspects of disease assessment and treatment.

Authors

Institutions

Publication Details

Journal
European Respiratory Journal
Published
2026-04-01
DOI
https://doi.org/10.1183/13993003.02125-2025
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Consensus definition of rapidly progressive interstitial lung disease: a critical unmet need to be led by pneumologists

Dov Taïeb, C. Diou, Yurdagül Uzunhan, Hilario Nunes
European Respiratory Journal
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Consensus definition of rapidly progressive interstitial lung disease: a critical unmet need to be led by pneumologists

Dov Taïeb, C. Diou, Yurdagül Uzunhan, Hilario Nunes
article en

Abstract

<title>Extract</title> The recent European Respiratory Society (ERS)/European Alliance of Associations for Rheumatology (EULAR) clinical practice guidelines for connective tissue disease-associated interstitial lung disease (CTD-ILD) represent a commendable collaborative effort and an important step toward harmonising clinical practice and improving outcomes for patients with these complex disorders [1, 2]. We commend the authors for addressing key aspects of disease assessment and treatment.

European Respiratory JournalVol. 67(4)
Inserm (FR), Sorbonne Université (FR), Université Sorbonne Paris Nord (FR), Hôpital Avicenne (FR)
Bristol-Myers Squibb, Pfizer, Sanofi
Openalex Percentile: Top 23%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.